Dave Stewart

Chief Technology & Transformation Officer

Dave Stewart currently serves as Chief Technology and Transformation Officer and has more than two decades of biotech leadership experience. He is a successful transformational leader in the CDMO industry and has excelled in leading diverse, multi-disciplinary teams while driving customer deliverables. He most recently served as SVP Capital Projects for Eli Lilly. Prior to this role, Mr. Stewart held roles leading global engineering and project execution, supply and operational readiness at Fujifilm Diosynth Biotechnologies in Denmark and Holly Springs, NC and as GM/Site Head of AGC Biologics in Boulder, CO. He was Site Quality Head of the Biogen Next Generation Manufacturing facility in Solothurn, Switzerland, and was with Genentech in Oceanside, CA as Head of Manufacturing Sciences & Technology, responsible for Process Engineering, Product Technical Transfer, Lab and Pilot Plant operations, Automation Engineering and Technical Validation. 

Mr. Stewart has a Bachelor of Science degree from Southern Illinois University, a Master of Science degree in Process Control from Indiana State University, and an eMBA from Quantic University. 

Mr. Stewart is a husband and father to three grown daughters. He enjoys running, skiing, hiking, and all-things outdoors.  

View LinkedIn Profile